nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxaprozin—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.197	0.306	CbGbCtD
Oxaprozin—PTGS2—Etoposide—uterine cancer	0.172	0.267	CbGbCtD
Oxaprozin—PTGS1—Etoposide—uterine cancer	0.145	0.225	CbGbCtD
Oxaprozin—CYP2C9—Progesterone—uterine cancer	0.131	0.203	CbGbCtD
Oxaprozin—PTGS1—oviduct—uterine cancer	0.00547	0.143	CbGeAlD
Oxaprozin—PTGS1—artery—uterine cancer	0.00362	0.0944	CbGeAlD
Oxaprozin—PTGS2—artery—uterine cancer	0.00346	0.0902	CbGeAlD
Oxaprozin—PTGS2—myometrium—uterine cancer	0.00167	0.0436	CbGeAlD
Oxaprozin—PTGS1—epithelium—uterine cancer	0.00137	0.0358	CbGeAlD
Oxaprozin—PTGS1—uterine cervix—uterine cancer	0.00136	0.0355	CbGeAlD
Oxaprozin—PTGS1—smooth muscle tissue—uterine cancer	0.00132	0.0345	CbGeAlD
Oxaprozin—PTGS2—epithelium—uterine cancer	0.00131	0.0342	CbGeAlD
Oxaprozin—PTGS2—uterine cervix—uterine cancer	0.0013	0.0339	CbGeAlD
Oxaprozin—PTGS1—renal system—uterine cancer	0.00127	0.0332	CbGeAlD
Oxaprozin—PTGS2—smooth muscle tissue—uterine cancer	0.00127	0.033	CbGeAlD
Oxaprozin—PTGS1—endometrium—uterine cancer	0.00123	0.0321	CbGeAlD
Oxaprozin—PTGS2—renal system—uterine cancer	0.00122	0.0317	CbGeAlD
Oxaprozin—PTGS1—mammalian vulva—uterine cancer	0.00119	0.031	CbGeAlD
Oxaprozin—PTGS2—endometrium—uterine cancer	0.00118	0.0307	CbGeAlD
Oxaprozin—PTGS1—uterus—uterine cancer	0.00114	0.0296	CbGeAlD
Oxaprozin—CYP2C9—female reproductive system—uterine cancer	0.00112	0.0291	CbGeAlD
Oxaprozin—PTGS2—uterus—uterine cancer	0.00109	0.0283	CbGeAlD
Oxaprozin—PTGS1—female reproductive system—uterine cancer	0.00102	0.0266	CbGeAlD
Oxaprozin—PTGS2—female reproductive system—uterine cancer	0.000975	0.0254	CbGeAlD
Oxaprozin—PTGS1—female gonad—uterine cancer	0.000929	0.0242	CbGeAlD
Oxaprozin—PTGS1—vagina—uterine cancer	0.000923	0.024	CbGeAlD
Oxaprozin—PTGS2—female gonad—uterine cancer	0.000888	0.0231	CbGeAlD
Oxaprozin—PTGS2—vagina—uterine cancer	0.000882	0.023	CbGeAlD
Oxaprozin—Bifonazole—CYP19A1—uterine cancer	0.000738	0.694	CrCbGaD
Oxaprozin—Aplastic anaemia—Doxorubicin—uterine cancer	0.000602	0.00191	CcSEcCtD
Oxaprozin—Sepsis—Epirubicin—uterine cancer	0.000601	0.00191	CcSEcCtD
Oxaprozin—PTGS1—lymph node—uterine cancer	0.000597	0.0156	CbGeAlD
Oxaprozin—Thrombocytopenia—Dactinomycin—uterine cancer	0.000597	0.00189	CcSEcCtD
Oxaprozin—Diarrhoea—Progesterone—uterine cancer	0.00059	0.00187	CcSEcCtD
Oxaprozin—Lymphadenopathy—Epirubicin—uterine cancer	0.00059	0.00187	CcSEcCtD
Oxaprozin—Erythema multiforme—Etoposide—uterine cancer	0.000587	0.00186	CcSEcCtD
Oxaprozin—Coma—Doxorubicin—uterine cancer	0.000586	0.00186	CcSEcCtD
Oxaprozin—Oesophagitis—Doxorubicin—uterine cancer	0.000586	0.00186	CcSEcCtD
Oxaprozin—Anorexia—Dactinomycin—uterine cancer	0.000581	0.00184	CcSEcCtD
Oxaprozin—Ecchymosis—Doxorubicin—uterine cancer	0.00058	0.00184	CcSEcCtD
Oxaprozin—Bladder pain—Doxorubicin—uterine cancer	0.00058	0.00184	CcSEcCtD
Oxaprozin—Photosensitivity—Epirubicin—uterine cancer	0.000573	0.00182	CcSEcCtD
Oxaprozin—PTGS2—lymph node—uterine cancer	0.000571	0.0149	CbGeAlD
Oxaprozin—Dizziness—Progesterone—uterine cancer	0.00057	0.00181	CcSEcCtD
Oxaprozin—Vascular purpura—Epirubicin—uterine cancer	0.000562	0.00179	CcSEcCtD
Oxaprozin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000561	0.00178	CcSEcCtD
Oxaprozin—Hepatic failure—Epirubicin—uterine cancer	0.00056	0.00178	CcSEcCtD
Oxaprozin—Sepsis—Doxorubicin—uterine cancer	0.000556	0.00177	CcSEcCtD
Oxaprozin—Cardiac failure congestive—Epirubicin—uterine cancer	0.000555	0.00176	CcSEcCtD
Oxaprozin—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000553	0.00175	CcSEcCtD
Oxaprozin—Alopecia—Etoposide—uterine cancer	0.000549	0.00174	CcSEcCtD
Oxaprozin—Vomiting—Progesterone—uterine cancer	0.000548	0.00174	CcSEcCtD
Oxaprozin—Lymphadenopathy—Doxorubicin—uterine cancer	0.000546	0.00173	CcSEcCtD
Oxaprozin—Renal failure acute—Epirubicin—uterine cancer	0.000545	0.00173	CcSEcCtD
Oxaprozin—Rash—Progesterone—uterine cancer	0.000544	0.00173	CcSEcCtD
Oxaprozin—Dermatitis—Progesterone—uterine cancer	0.000543	0.00172	CcSEcCtD
Oxaprozin—Headache—Progesterone—uterine cancer	0.00054	0.00171	CcSEcCtD
Oxaprozin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000535	0.0017	CcSEcCtD
Oxaprozin—Dermatitis exfoliative—Epirubicin—uterine cancer	0.000533	0.00169	CcSEcCtD
Oxaprozin—Photosensitivity—Doxorubicin—uterine cancer	0.00053	0.00168	CcSEcCtD
Oxaprozin—Decreased appetite—Dactinomycin—uterine cancer	0.00053	0.00168	CcSEcCtD
Oxaprozin—Dysgeusia—Etoposide—uterine cancer	0.000529	0.00168	CcSEcCtD
Oxaprozin—Renal impairment—Epirubicin—uterine cancer	0.000529	0.00168	CcSEcCtD
Oxaprozin—Purpura—Epirubicin—uterine cancer	0.000522	0.00166	CcSEcCtD
Oxaprozin—Vascular purpura—Doxorubicin—uterine cancer	0.00052	0.00165	CcSEcCtD
Oxaprozin—Anaphylactoid reaction—Epirubicin—uterine cancer	0.00052	0.00165	CcSEcCtD
Oxaprozin—Hepatic failure—Doxorubicin—uterine cancer	0.000518	0.00164	CcSEcCtD
Oxaprozin—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000517	0.00164	CcSEcCtD
Oxaprozin—Lethargy—Epirubicin—uterine cancer	0.000513	0.00163	CcSEcCtD
Oxaprozin—Cardiac failure congestive—Doxorubicin—uterine cancer	0.000513	0.00163	CcSEcCtD
Oxaprozin—Nausea—Progesterone—uterine cancer	0.000512	0.00163	CcSEcCtD
Oxaprozin—Renal failure acute—Doxorubicin—uterine cancer	0.000504	0.0016	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000503	0.0016	CcSEcCtD
Oxaprozin—Feeling abnormal—Dactinomycin—uterine cancer	0.000502	0.00159	CcSEcCtD
Oxaprozin—Ill-defined disorder—Etoposide—uterine cancer	0.000501	0.00159	CcSEcCtD
Oxaprozin—Anaemia—Etoposide—uterine cancer	0.0005	0.00159	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000498	0.00158	CcSEcCtD
Oxaprozin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000497	0.00158	CcSEcCtD
Oxaprozin—Dermatitis exfoliative—Doxorubicin—uterine cancer	0.000493	0.00157	CcSEcCtD
Oxaprozin—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000493	0.00156	CcSEcCtD
Oxaprozin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000492	0.00156	CcSEcCtD
Oxaprozin—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000489	0.00155	CcSEcCtD
Oxaprozin—Renal impairment—Doxorubicin—uterine cancer	0.000489	0.00155	CcSEcCtD
Oxaprozin—Malaise—Etoposide—uterine cancer	0.000487	0.00155	CcSEcCtD
Oxaprozin—Vertigo—Etoposide—uterine cancer	0.000486	0.00154	CcSEcCtD
Oxaprozin—Leukopenia—Etoposide—uterine cancer	0.000484	0.00154	CcSEcCtD
Oxaprozin—Purpura—Doxorubicin—uterine cancer	0.000483	0.00153	CcSEcCtD
Oxaprozin—Abdominal pain—Dactinomycin—uterine cancer	0.000482	0.00153	CcSEcCtD
Oxaprozin—Body temperature increased—Dactinomycin—uterine cancer	0.000482	0.00153	CcSEcCtD
Oxaprozin—Anaphylactoid reaction—Doxorubicin—uterine cancer	0.000481	0.00153	CcSEcCtD
Oxaprozin—Loss of consciousness—Etoposide—uterine cancer	0.000475	0.00151	CcSEcCtD
Oxaprozin—Lethargy—Doxorubicin—uterine cancer	0.000475	0.00151	CcSEcCtD
Oxaprozin—Convulsion—Etoposide—uterine cancer	0.000468	0.00149	CcSEcCtD
Oxaprozin—Hypertension—Etoposide—uterine cancer	0.000467	0.00148	CcSEcCtD
Oxaprozin—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000465	0.00148	CcSEcCtD
Oxaprozin—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000464	0.00147	CcSEcCtD
Oxaprozin—Abdominal pain upper—Epirubicin—uterine cancer	0.000459	0.00146	CcSEcCtD
Oxaprozin—Discomfort—Etoposide—uterine cancer	0.000455	0.00144	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.000453	0.00144	CcSEcCtD
Oxaprozin—Gastritis—Epirubicin—uterine cancer	0.000445	0.00141	CcSEcCtD
Oxaprozin—Confusional state—Etoposide—uterine cancer	0.000445	0.00141	CcSEcCtD
Oxaprozin—Anaphylactic shock—Etoposide—uterine cancer	0.000441	0.0014	CcSEcCtD
Oxaprozin—Infection—Etoposide—uterine cancer	0.000438	0.00139	CcSEcCtD
Oxaprozin—Asthenia—Dactinomycin—uterine cancer	0.000437	0.00139	CcSEcCtD
Oxaprozin—Asthma—Epirubicin—uterine cancer	0.000435	0.00138	CcSEcCtD
Oxaprozin—Thrombocytopenia—Etoposide—uterine cancer	0.000432	0.00137	CcSEcCtD
Oxaprozin—Tachycardia—Etoposide—uterine cancer	0.00043	0.00137	CcSEcCtD
Oxaprozin—Eosinophilia—Epirubicin—uterine cancer	0.00043	0.00137	CcSEcCtD
Oxaprozin—Hyperhidrosis—Etoposide—uterine cancer	0.000426	0.00135	CcSEcCtD
Oxaprozin—Pancreatitis—Epirubicin—uterine cancer	0.000426	0.00135	CcSEcCtD
Oxaprozin—Abdominal pain upper—Doxorubicin—uterine cancer	0.000425	0.00135	CcSEcCtD
Oxaprozin—Anorexia—Etoposide—uterine cancer	0.00042	0.00133	CcSEcCtD
Oxaprozin—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.000419	0.00133	CcSEcCtD
Oxaprozin—Diarrhoea—Dactinomycin—uterine cancer	0.000417	0.00132	CcSEcCtD
Oxaprozin—Pancytopenia—Epirubicin—uterine cancer	0.000413	0.00131	CcSEcCtD
Oxaprozin—Hypotension—Etoposide—uterine cancer	0.000412	0.00131	CcSEcCtD
Oxaprozin—Gastritis—Doxorubicin—uterine cancer	0.000412	0.00131	CcSEcCtD
Oxaprozin—Dysuria—Epirubicin—uterine cancer	0.000407	0.00129	CcSEcCtD
Oxaprozin—Asthma—Doxorubicin—uterine cancer	0.000402	0.00128	CcSEcCtD
Oxaprozin—Eosinophilia—Doxorubicin—uterine cancer	0.000398	0.00126	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Epirubicin—uterine cancer	0.000397	0.00126	CcSEcCtD
Oxaprozin—Paraesthesia—Etoposide—uterine cancer	0.000396	0.00126	CcSEcCtD
Oxaprozin—Pancreatitis—Doxorubicin—uterine cancer	0.000394	0.00125	CcSEcCtD
Oxaprozin—Dyspnoea—Etoposide—uterine cancer	0.000393	0.00125	CcSEcCtD
Oxaprozin—Hyperglycaemia—Epirubicin—uterine cancer	0.000392	0.00124	CcSEcCtD
Oxaprozin—Somnolence—Etoposide—uterine cancer	0.000392	0.00124	CcSEcCtD
Oxaprozin—Pneumonia—Epirubicin—uterine cancer	0.00039	0.00124	CcSEcCtD
Oxaprozin—Drowsiness—Epirubicin—uterine cancer	0.000388	0.00123	CcSEcCtD
Oxaprozin—Vomiting—Dactinomycin—uterine cancer	0.000387	0.00123	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.000384	0.00122	CcSEcCtD
Oxaprozin—Rash—Dactinomycin—uterine cancer	0.000384	0.00122	CcSEcCtD
Oxaprozin—Decreased appetite—Etoposide—uterine cancer	0.000383	0.00122	CcSEcCtD
Oxaprozin—Pancytopenia—Doxorubicin—uterine cancer	0.000382	0.00121	CcSEcCtD
Oxaprozin—Renal failure—Epirubicin—uterine cancer	0.000381	0.00121	CcSEcCtD
Oxaprozin—Jaundice—Epirubicin—uterine cancer	0.000378	0.0012	CcSEcCtD
Oxaprozin—Stomatitis—Epirubicin—uterine cancer	0.000378	0.0012	CcSEcCtD
Oxaprozin—Constipation—Etoposide—uterine cancer	0.000377	0.0012	CcSEcCtD
Oxaprozin—Conjunctivitis—Epirubicin—uterine cancer	0.000377	0.0012	CcSEcCtD
Oxaprozin—Dysuria—Doxorubicin—uterine cancer	0.000376	0.00119	CcSEcCtD
Oxaprozin—Haematuria—Epirubicin—uterine cancer	0.00037	0.00117	CcSEcCtD
Oxaprozin—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000367	0.00117	CcSEcCtD
Oxaprozin—Sinusitis—Epirubicin—uterine cancer	0.000364	0.00115	CcSEcCtD
Oxaprozin—Feeling abnormal—Etoposide—uterine cancer	0.000363	0.00115	CcSEcCtD
Oxaprozin—Hyperglycaemia—Doxorubicin—uterine cancer	0.000363	0.00115	CcSEcCtD
Oxaprozin—Nausea—Dactinomycin—uterine cancer	0.000362	0.00115	CcSEcCtD
Oxaprozin—Agranulocytosis—Epirubicin—uterine cancer	0.000362	0.00115	CcSEcCtD
Oxaprozin—Pneumonia—Doxorubicin—uterine cancer	0.000361	0.00115	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Etoposide—uterine cancer	0.000361	0.00114	CcSEcCtD
Oxaprozin—Drowsiness—Doxorubicin—uterine cancer	0.000359	0.00114	CcSEcCtD
Oxaprozin—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000356	0.00113	CcSEcCtD
Oxaprozin—Renal failure—Doxorubicin—uterine cancer	0.000353	0.00112	CcSEcCtD
Oxaprozin—Urticaria—Etoposide—uterine cancer	0.00035	0.00111	CcSEcCtD
Oxaprozin—Haemoglobin—Epirubicin—uterine cancer	0.00035	0.00111	CcSEcCtD
Oxaprozin—Stomatitis—Doxorubicin—uterine cancer	0.00035	0.00111	CcSEcCtD
Oxaprozin—Jaundice—Doxorubicin—uterine cancer	0.00035	0.00111	CcSEcCtD
Oxaprozin—Abdominal pain—Etoposide—uterine cancer	0.000349	0.00111	CcSEcCtD
Oxaprozin—Body temperature increased—Etoposide—uterine cancer	0.000349	0.00111	CcSEcCtD
Oxaprozin—Conjunctivitis—Doxorubicin—uterine cancer	0.000349	0.00111	CcSEcCtD
Oxaprozin—Haemorrhage—Epirubicin—uterine cancer	0.000348	0.0011	CcSEcCtD
Oxaprozin—Hepatitis—Epirubicin—uterine cancer	0.000348	0.0011	CcSEcCtD
Oxaprozin—Haematuria—Doxorubicin—uterine cancer	0.000342	0.00109	CcSEcCtD
Oxaprozin—Sinusitis—Doxorubicin—uterine cancer	0.000337	0.00107	CcSEcCtD
Oxaprozin—Agranulocytosis—Doxorubicin—uterine cancer	0.000335	0.00106	CcSEcCtD
Oxaprozin—Erythema multiforme—Epirubicin—uterine cancer	0.000329	0.00104	CcSEcCtD
Oxaprozin—Methadone—CYP19A1—uterine cancer	0.000325	0.306	CrCbGaD
Oxaprozin—Tinnitus—Epirubicin—uterine cancer	0.000324	0.00103	CcSEcCtD
Oxaprozin—Haemoglobin—Doxorubicin—uterine cancer	0.000324	0.00103	CcSEcCtD
Oxaprozin—Hepatitis—Doxorubicin—uterine cancer	0.000322	0.00102	CcSEcCtD
Oxaprozin—Haemorrhage—Doxorubicin—uterine cancer	0.000322	0.00102	CcSEcCtD
Oxaprozin—Asthenia—Etoposide—uterine cancer	0.000316	0.001	CcSEcCtD
Oxaprozin—Pruritus—Etoposide—uterine cancer	0.000312	0.000991	CcSEcCtD
Oxaprozin—Arrhythmia—Epirubicin—uterine cancer	0.000311	0.000987	CcSEcCtD
Oxaprozin—Alopecia—Epirubicin—uterine cancer	0.000308	0.000976	CcSEcCtD
Oxaprozin—Erythema multiforme—Doxorubicin—uterine cancer	0.000304	0.000966	CcSEcCtD
Oxaprozin—Diarrhoea—Etoposide—uterine cancer	0.000302	0.000958	CcSEcCtD
Oxaprozin—Tinnitus—Doxorubicin—uterine cancer	0.0003	0.000953	CcSEcCtD
Oxaprozin—Flatulence—Epirubicin—uterine cancer	0.000299	0.000948	CcSEcCtD
Oxaprozin—Tension—Epirubicin—uterine cancer	0.000297	0.000944	CcSEcCtD
Oxaprozin—Dysgeusia—Epirubicin—uterine cancer	0.000297	0.000942	CcSEcCtD
Oxaprozin—Nervousness—Epirubicin—uterine cancer	0.000294	0.000934	CcSEcCtD
Oxaprozin—Dizziness—Etoposide—uterine cancer	0.000292	0.000926	CcSEcCtD
Oxaprozin—Arrhythmia—Doxorubicin—uterine cancer	0.000288	0.000913	CcSEcCtD
Oxaprozin—Vision blurred—Epirubicin—uterine cancer	0.000286	0.000906	CcSEcCtD
Oxaprozin—Alopecia—Doxorubicin—uterine cancer	0.000285	0.000903	CcSEcCtD
Oxaprozin—Ill-defined disorder—Epirubicin—uterine cancer	0.000281	0.000892	CcSEcCtD
Oxaprozin—Vomiting—Etoposide—uterine cancer	0.00028	0.00089	CcSEcCtD
Oxaprozin—Anaemia—Epirubicin—uterine cancer	0.00028	0.000889	CcSEcCtD
Oxaprozin—Rash—Etoposide—uterine cancer	0.000278	0.000883	CcSEcCtD
Oxaprozin—Dermatitis—Etoposide—uterine cancer	0.000278	0.000882	CcSEcCtD
Oxaprozin—Headache—Etoposide—uterine cancer	0.000276	0.000877	CcSEcCtD
Oxaprozin—Flatulence—Doxorubicin—uterine cancer	0.000276	0.000877	CcSEcCtD
Oxaprozin—Tension—Doxorubicin—uterine cancer	0.000275	0.000873	CcSEcCtD
Oxaprozin—Dysgeusia—Doxorubicin—uterine cancer	0.000274	0.000871	CcSEcCtD
Oxaprozin—Malaise—Epirubicin—uterine cancer	0.000273	0.000867	CcSEcCtD
Oxaprozin—Nervousness—Doxorubicin—uterine cancer	0.000272	0.000864	CcSEcCtD
Oxaprozin—Vertigo—Epirubicin—uterine cancer	0.000272	0.000864	CcSEcCtD
Oxaprozin—Syncope—Epirubicin—uterine cancer	0.000272	0.000862	CcSEcCtD
Oxaprozin—Leukopenia—Epirubicin—uterine cancer	0.000271	0.000861	CcSEcCtD
Oxaprozin—Palpitations—Epirubicin—uterine cancer	0.000268	0.00085	CcSEcCtD
Oxaprozin—Loss of consciousness—Epirubicin—uterine cancer	0.000266	0.000845	CcSEcCtD
Oxaprozin—Vision blurred—Doxorubicin—uterine cancer	0.000264	0.000839	CcSEcCtD
Oxaprozin—Convulsion—Epirubicin—uterine cancer	0.000262	0.000833	CcSEcCtD
Oxaprozin—Nausea—Etoposide—uterine cancer	0.000262	0.000832	CcSEcCtD
Oxaprozin—Hypertension—Epirubicin—uterine cancer	0.000262	0.00083	CcSEcCtD
Oxaprozin—Ill-defined disorder—Doxorubicin—uterine cancer	0.00026	0.000826	CcSEcCtD
Oxaprozin—Anaemia—Doxorubicin—uterine cancer	0.000259	0.000822	CcSEcCtD
Oxaprozin—Anxiety—Epirubicin—uterine cancer	0.000257	0.000816	CcSEcCtD
Oxaprozin—Discomfort—Epirubicin—uterine cancer	0.000255	0.000809	CcSEcCtD
Oxaprozin—Malaise—Doxorubicin—uterine cancer	0.000253	0.000802	CcSEcCtD
Oxaprozin—Dry mouth—Epirubicin—uterine cancer	0.000252	0.000801	CcSEcCtD
Oxaprozin—Vertigo—Doxorubicin—uterine cancer	0.000252	0.000799	CcSEcCtD
Oxaprozin—Syncope—Doxorubicin—uterine cancer	0.000251	0.000798	CcSEcCtD
Oxaprozin—Leukopenia—Doxorubicin—uterine cancer	0.000251	0.000796	CcSEcCtD
Oxaprozin—Confusional state—Epirubicin—uterine cancer	0.000249	0.000791	CcSEcCtD
Oxaprozin—Palpitations—Doxorubicin—uterine cancer	0.000248	0.000786	CcSEcCtD
Oxaprozin—Oedema—Epirubicin—uterine cancer	0.000247	0.000785	CcSEcCtD
Oxaprozin—Anaphylactic shock—Epirubicin—uterine cancer	0.000247	0.000785	CcSEcCtD
Oxaprozin—Loss of consciousness—Doxorubicin—uterine cancer	0.000246	0.000782	CcSEcCtD
Oxaprozin—Infection—Epirubicin—uterine cancer	0.000246	0.00078	CcSEcCtD
Oxaprozin—Shock—Epirubicin—uterine cancer	0.000243	0.000772	CcSEcCtD
Oxaprozin—Convulsion—Doxorubicin—uterine cancer	0.000243	0.000771	CcSEcCtD
Oxaprozin—Thrombocytopenia—Epirubicin—uterine cancer	0.000242	0.000768	CcSEcCtD
Oxaprozin—Hypertension—Doxorubicin—uterine cancer	0.000242	0.000768	CcSEcCtD
Oxaprozin—Tachycardia—Epirubicin—uterine cancer	0.000241	0.000766	CcSEcCtD
Oxaprozin—Hyperhidrosis—Epirubicin—uterine cancer	0.000239	0.000759	CcSEcCtD
Oxaprozin—Anxiety—Doxorubicin—uterine cancer	0.000238	0.000755	CcSEcCtD
Oxaprozin—Discomfort—Doxorubicin—uterine cancer	0.000236	0.000748	CcSEcCtD
Oxaprozin—Anorexia—Epirubicin—uterine cancer	0.000236	0.000748	CcSEcCtD
Oxaprozin—Dry mouth—Doxorubicin—uterine cancer	0.000233	0.000741	CcSEcCtD
Oxaprozin—Hypotension—Epirubicin—uterine cancer	0.000231	0.000733	CcSEcCtD
Oxaprozin—Confusional state—Doxorubicin—uterine cancer	0.000231	0.000732	CcSEcCtD
Oxaprozin—Oedema—Doxorubicin—uterine cancer	0.000229	0.000726	CcSEcCtD
Oxaprozin—Anaphylactic shock—Doxorubicin—uterine cancer	0.000229	0.000726	CcSEcCtD
Oxaprozin—Infection—Doxorubicin—uterine cancer	0.000227	0.000721	CcSEcCtD
Oxaprozin—Shock—Doxorubicin—uterine cancer	0.000225	0.000714	CcSEcCtD
Oxaprozin—Thrombocytopenia—Doxorubicin—uterine cancer	0.000224	0.000711	CcSEcCtD
Oxaprozin—Insomnia—Epirubicin—uterine cancer	0.000224	0.00071	CcSEcCtD
Oxaprozin—Tachycardia—Doxorubicin—uterine cancer	0.000223	0.000709	CcSEcCtD
Oxaprozin—Paraesthesia—Epirubicin—uterine cancer	0.000222	0.000705	CcSEcCtD
Oxaprozin—Hyperhidrosis—Doxorubicin—uterine cancer	0.000221	0.000702	CcSEcCtD
Oxaprozin—Dyspnoea—Epirubicin—uterine cancer	0.00022	0.0007	CcSEcCtD
Oxaprozin—Somnolence—Epirubicin—uterine cancer	0.00022	0.000698	CcSEcCtD
Oxaprozin—Anorexia—Doxorubicin—uterine cancer	0.000218	0.000692	CcSEcCtD
Oxaprozin—Dyspepsia—Epirubicin—uterine cancer	0.000218	0.000691	CcSEcCtD
Oxaprozin—Decreased appetite—Epirubicin—uterine cancer	0.000215	0.000682	CcSEcCtD
Oxaprozin—Hypotension—Doxorubicin—uterine cancer	0.000214	0.000679	CcSEcCtD
Oxaprozin—Constipation—Epirubicin—uterine cancer	0.000211	0.000671	CcSEcCtD
Oxaprozin—Insomnia—Doxorubicin—uterine cancer	0.000207	0.000657	CcSEcCtD
Oxaprozin—Paraesthesia—Doxorubicin—uterine cancer	0.000205	0.000652	CcSEcCtD
Oxaprozin—Dyspnoea—Doxorubicin—uterine cancer	0.000204	0.000647	CcSEcCtD
Oxaprozin—Feeling abnormal—Epirubicin—uterine cancer	0.000204	0.000647	CcSEcCtD
Oxaprozin—Somnolence—Doxorubicin—uterine cancer	0.000203	0.000646	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Epirubicin—uterine cancer	0.000202	0.000642	CcSEcCtD
Oxaprozin—Dyspepsia—Doxorubicin—uterine cancer	0.000201	0.000639	CcSEcCtD
Oxaprozin—Decreased appetite—Doxorubicin—uterine cancer	0.000199	0.000631	CcSEcCtD
Oxaprozin—Urticaria—Epirubicin—uterine cancer	0.000196	0.000623	CcSEcCtD
Oxaprozin—Constipation—Doxorubicin—uterine cancer	0.000196	0.000621	CcSEcCtD
Oxaprozin—Body temperature increased—Epirubicin—uterine cancer	0.000195	0.00062	CcSEcCtD
Oxaprozin—Abdominal pain—Epirubicin—uterine cancer	0.000195	0.00062	CcSEcCtD
Oxaprozin—Feeling abnormal—Doxorubicin—uterine cancer	0.000189	0.000598	CcSEcCtD
Oxaprozin—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000187	0.000594	CcSEcCtD
Oxaprozin—Urticaria—Doxorubicin—uterine cancer	0.000182	0.000577	CcSEcCtD
Oxaprozin—Abdominal pain—Doxorubicin—uterine cancer	0.000181	0.000574	CcSEcCtD
Oxaprozin—Body temperature increased—Doxorubicin—uterine cancer	0.000181	0.000574	CcSEcCtD
Oxaprozin—Asthenia—Epirubicin—uterine cancer	0.000177	0.000563	CcSEcCtD
Oxaprozin—Pruritus—Epirubicin—uterine cancer	0.000175	0.000555	CcSEcCtD
Oxaprozin—Diarrhoea—Epirubicin—uterine cancer	0.000169	0.000537	CcSEcCtD
Oxaprozin—Asthenia—Doxorubicin—uterine cancer	0.000164	0.000521	CcSEcCtD
Oxaprozin—Dizziness—Epirubicin—uterine cancer	0.000163	0.000519	CcSEcCtD
Oxaprozin—Pruritus—Doxorubicin—uterine cancer	0.000162	0.000514	CcSEcCtD
Oxaprozin—Vomiting—Epirubicin—uterine cancer	0.000157	0.000499	CcSEcCtD
Oxaprozin—Diarrhoea—Doxorubicin—uterine cancer	0.000157	0.000497	CcSEcCtD
Oxaprozin—Rash—Epirubicin—uterine cancer	0.000156	0.000495	CcSEcCtD
Oxaprozin—Dermatitis—Epirubicin—uterine cancer	0.000156	0.000494	CcSEcCtD
Oxaprozin—Headache—Epirubicin—uterine cancer	0.000155	0.000492	CcSEcCtD
Oxaprozin—Dizziness—Doxorubicin—uterine cancer	0.000151	0.00048	CcSEcCtD
Oxaprozin—Nausea—Epirubicin—uterine cancer	0.000147	0.000466	CcSEcCtD
Oxaprozin—Vomiting—Doxorubicin—uterine cancer	0.000145	0.000462	CcSEcCtD
Oxaprozin—Rash—Doxorubicin—uterine cancer	0.000144	0.000458	CcSEcCtD
Oxaprozin—Dermatitis—Doxorubicin—uterine cancer	0.000144	0.000457	CcSEcCtD
Oxaprozin—Headache—Doxorubicin—uterine cancer	0.000143	0.000455	CcSEcCtD
Oxaprozin—Nausea—Doxorubicin—uterine cancer	0.000136	0.000431	CcSEcCtD
